ArticleBMJ open diabetes research & care2023

Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study.

Stephen C Bain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.